Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) | |
Zhou, J.; Eng-Wong, J.; Mao, Y.; Althaus, B.; Liao, N.; Wang, Y.; Wang, C.; Chang, Y-C; Wang, H.; Kang, S. Y. | |
2019 | |
卷号 | 79 |
期号 | 4 |
会议录 | CANCER RESEARCH |
语种 | 英语 |
URL标识 | 查看原文 |
ISSN号 | 0008-5472 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3594473 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhou, J.,Eng-Wong, J.,Mao, Y.,et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论